CDK4 and soft tissue sarcoma: Clinical data from the GEPIA dataset confirms that CDK4, CCT2, and MGAT1 expression levels are highly correlated with prognosis, and that up-regulation may lead to a significant reduction in survival time in patients with soft tissue sarcoma.